Andrea McClatchey, PhD

Andrea McClatchey, PhD

2012 Honoree

Researcher, Center for Cancer Research

As the Patricia and Scott Eston Research Scholar at Massachusetts General Hospital, Andrea McClatchey, PhD, was one of five faculty members selected from more than 120 researchers for the newly created prestigious Research Scholar Award. A professor of Pathology at Harvard Medical School, Dr. McClatchey is the first woman faculty member to achieve the rank of professor in the Center for Cancer Research. Her work has focused on the molecular basis of neurofibromatosis type 2 (NF2), a familial cancer syndrome caused by mutation of the NF2 tumor suppressor gene. Patients with this gene are genetically predisposed to develop tumors that grow within the cranial and spinal nerves, particularly those of the ear, causing hearing loss and progressive neurological complications. Dr. McClatchey’s research uncovered fundamental rules by which contact between adjacent cells governs their proliferation and revealed that these rules are broken by many types of tumors. This may ultimately lead to new therapeutic approaches for individuals suffering from this disease and other human cancers, as well as a better appreciation of the link between normal development and cancer.

The 2013 one hundred event is June 5 at the Westin Boston Waterfront

Get Tickets Become a Sponsor

Mass General honors 100 individuals and groups for their diverse contributions to the fight against cancer.

There is strength in numbers and Massachusetts General Hospital Cancer Center proves this each year. the one hundred is the Cancer Center’s annual fundraiser, honoring 100 individuals and groups whose diligence and discoveries, philanthropy and passion have helped advance the fight against cancer. Funds raised at the gala support research, patient care, education and community outreach programs.  Meet the Honorees.

Navigation


2012 Gala Event
See video and photos from the 2012 event

Search For An Honoree

Enter the name of the honoree, or search by the year of their nomination.

Follow Us on Twitter